Allworth Financial’s Zomedica Corp. ZOM Stock Holding History

Allworth Financial’s Portfolio ZOM Stock Details ZOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-34,273	Closed	-$12K	–	2990
2022 Q1	$12K	Buy	+34,273	New	+$11.2K	﹤0.01%	1448

Other funds holding ZOM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

PWMG

Pinnacle Wealth Management Group Plymouth, Michigan $214M AUM 20.07% 1-Year Est. Return

Allworth Financial's ZOM Position: Q2 2022 in Review

Allworth Financial sold out of Zomedica Corp. (ZOM) in Q2 2022, closing a stake of 34,273 shares — an estimated $12K sold.

Allworth Financial first reported a position in ZOM in Q1 2022 and held it in 1 quarter. The position peaked at $12K in Q1 2022. 97 funds tracked by Wall St. Rank hold ZOM as of Q2 2022.

Allworth Financial reported no remaining Zomedica Corp. position as of Q2 2022 after selling out during the quarter.
Allworth Financial sold 34,273 Zomedica Corp. shares in Q2 2022, an estimated $12K.
Allworth Financial first reported a position in Zomedica Corp. in Q1 2022 and held it in 1 quarter.
Allworth Financial's Zomedica Corp. position peaked at $12K in Q1 2022.
97 funds tracked by Wall St. Rank held Zomedica Corp. as of Q2 2022.

Based on Allworth Financial's 13F filing for Q2 2022, filed 13 Jul 2022.